Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP
Authors:
- M. YamamotoMYM. Yamamoto
- M. HirayamaMHM. Hirayama
- F. TanakaFTF. Tanaka
- M. KatsunoMKM. Katsuno
- K. MoriKMK. Mori
- H. KoikeHKH. Koike
- N. HattoriNHN. Hattori
- K. ArimuraKAK. Arimura
- M. NakagawaMNM. Nakagawa
- H. YoshikawaHYH. Yoshikawa
- K. HayasakaKHK. Hayasaka
- 26 April 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (8) , 1471-1475
Abstract
To identify clinical and electrophysiologic features related to IV immunoglobulin (IVIg) responsiveness in chronic inflammatory demyelinating polyneuropathy (CIDP), the authors conducted a multicenter study on 312 patients with CIDP (199 responders and 113 nonresponders). Muscle atrophy and decreased compound muscle action potential were pronounced in nonresponders of IVIg. Male gender, longer disease duration, and slow progression of symptoms were also associated with IVIg unresponsiveness. Features suggesting axonal dysfunction in peripheral nerves indicated IVIg unresponsiveness in CIDP.Keywords
This publication has 8 references indexed in Scilit:
- Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP) – diagnosis confirmed by nerve biopsyNeurophysiologie Clinique, 2004
- Alcoholic neuropathy is clinicopathologically distinct from thiamine‐deficiency neuropathyAnnals of Neurology, 2003
- Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathiesJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Abnormal Schwann Cell‐Axon Interactions in CMT Neuropathies: The Effects of Mutant Schwann Cells on the Axonal Cytoskeleton and Regeneration‐Associated MyelinationAnnals of the New York Academy of Sciences, 1999
- Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, cross-over studyBrain, 1996
- Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)Neurology, 1991
- Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating PolyneuropathyArchives of Neurology, 1991
- High‐dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathyNeurology, 1990